Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

Purpose: For high-risk prostate cancer (HR-PCa) in men with a life expectancy of at least 10 years, the National Comprehensive Cancer Network recommends radiation therapy (RT) plus androgen deprivation therapy (ADT) with category 1 evidence or radical prostatectomy (RP) as an acceptable initial ther...

Full description

Bibliographic Details
Main Authors: Stephanie Markovina, MD, PhD, Marshall W. Meeks, MD, Shahed Badiyan, MD, Joel Vetter, MS, Hiram A. Gay, MD, Alethea Paradis, MTS, Jeff Michalski, MD, MBA, Gurdarshan Sandhu, MD
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109417302300

Similar Items

Similar Items